Investment Research and Business Due Diligence
Wednesday, July 3, 2013
Sandoz launches generic metronidazole in the US
Sandoz has launched metronidazole 1% topical gel, the first generic version of METROGEL® 1%.
Metronidazole 1% topical gel is indicated for the topical treatment of inflammatory lesions of rosacea. According to IMS Health, US sales for branded metronidazole 1% topical gel were USD 110 million for the 12 months ending in April 2013. Galderma is the innovator for Metronidazole.With Sandoz being the only player on the market, we expect it to garner about 40 percent market share a ta price discount of 40 percent in 2013. This should add about $30m to Sandoz sales.
Enter your email address:
Share to Twitter
Share to Facebook
Share to Pinterest
Post Comments (Atom)